ALFA FinderBSE filing, BSE: 544920. Summary written from the filing by ALFA Finder's alert engine.
Amtech Esters Ltd: key numbers
- Share price
- ₹78.16
- Market cap
- ₹69.01 Cr
- Revenue (annual)
- ₹40.67 Cr
- Net profit (annual)
- ₹4.22 Cr
- P/E (TTM)
- 16.3×Sector 35.1×
- Promoter holding
- 45.52%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amtech Esters Ltd
All →Amtech Esters H1 FY27 Results: Net Profit ₹2.3 Cr, Up 76.9% YoY
Amtech Esters Limited approved its unaudited standalone and consolidated financial results for the half-year ended September 30, 2026.
- Key figure
- Net profit ₹2.3 Cr · +76.9% YoY
Amtech Esters Board Meeting Date
Amtech Esters Ltd has informed BSE that its Board meets on 13 November 2026 to consider unaudited standalone and consolidated half-year results. The intimation is a Regulation 29 prior notice of the meeting.
Amtech Esters Production Started
Amtech Esters started commercial production at its new Haryana plant on 2 November 2026. The plant adds 4,800 MTPA of resin capacity, reaching 7,760 MTPA.
- unsaturated polyester resin manufacturing capacity
- 4800.0 MTPA
Amtech Esters Price Movement Clarification
Amtech Esters Ltd clarified that the recent significant movement in its share price is driven by market dynamics. The company confirmed no undisclosed material information exists.
Amtech Esters Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026. This filing is a routine disclosure of shareholding structure.
Amtech Esters Capacity Expansion
Amtech Esters Limited has completed installation and commenced trial production at its new manufacturing plant in Asoda, Haryana, adding 4,800 MTPA to its capacity.
- Unsaturated Polyester Resins (UPR) capacity
- 4800.0 MTPA
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr